99 related articles for article (PubMed ID: 10569135)
21. Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease.
Vaiphei K; Kumari N; Sinha SK; Dutta U; Nagi B; Joshi K; Singh K
World J Gastroenterol; 2006 Jun; 12(22):3602-8. PubMed ID: 16773719
[TBL] [Abstract][Full Text] [Related]
22. Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma.
Shah L; Walter KL; Borczuk AC; Kawut SM; Sonett JR; Gorenstein LA; Ginsburg ME; Steinglass KM; Powell CA
Cancer; 2004 Oct; 101(7):1632-8. PubMed ID: 15378500
[TBL] [Abstract][Full Text] [Related]
23. Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases.
Coupland SE; Hellmich M; Auw-Haedrich C; Lee WR; Anagnostopoulos I; Stein H
Br J Ophthalmol; 2005 Mar; 89(3):352-9. PubMed ID: 15722318
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic significance of CD40, CD40L, and CD26 expression in Hodgkin's disease and other lymphomas.
Carbone A; Gloghini A
Am J Clin Pathol; 1996 Apr; 105(4):522-3. PubMed ID: 8604696
[No Abstract] [Full Text] [Related]
25. [Syndecan-1 (CD138): an immunohistochemical marker of plasma cell tumors].
Fakan F; Boudová L; Hejda C
Cesk Patol; 2002 Jan; 38(1):33-6. PubMed ID: 11933459
[TBL] [Abstract][Full Text] [Related]
26. Large B-cell lymphoma with Hodgkin's features.
García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
[TBL] [Abstract][Full Text] [Related]
27. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
[TBL] [Abstract][Full Text] [Related]
28. Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases.
Tzankov A; Zimpfer A; Pehrs AC; Lugli A; Went P; Maurer R; Pileri S; Dirnhofer S
Mod Pathol; 2003 Nov; 16(11):1141-7. PubMed ID: 14614054
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of soluble syndecan-1 in Hodgkin's lymphoma.
Vassilakopoulos TP; Kyrtsonis MC; Papadogiannis A; Nadali G; Angelopoulou MK; Tzenou T; Dimopoulou MN; Siakantaris MP; Kontopidou FN; Kalpadakis C; Kokoris SI; Dimitriadou EM; Tsaftaridis P; Pizzolo G; Pangalis GA
Anticancer Res; 2005; 25(6C):4743-6. PubMed ID: 16334170
[TBL] [Abstract][Full Text] [Related]
30. Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen.
Gaidano G; Gloghini A; Gattei V; Rossi MF; Cilia AM; Godeas C; Degan M; Perin T; Canzonieri V; Aldinucci D; Saglio G; Carbone A; Pinto A
Blood; 1997 Dec; 90(12):4894-900. PubMed ID: 9389706
[TBL] [Abstract][Full Text] [Related]
31. Incidental oral plasmablastic lymphoma with aberrant expression of CD4 in an elderly HIV-negative patient: how a gingival polyp can cause confusion.
Tzankov A; Brunhuber T; Gschwendtner A; Brunner A
Histopathology; 2005 Mar; 46(3):348-50. PubMed ID: 15720425
[No Abstract] [Full Text] [Related]
32. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
[TBL] [Abstract][Full Text] [Related]
33. Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas.
Sebestyén A; Berczi L; Mihalik R; Paku S; Matolcsy A; Kopper L
Br J Haematol; 1999 Feb; 104(2):412-9. PubMed ID: 10050727
[TBL] [Abstract][Full Text] [Related]
34. Cell-surface proteoglycan expression by lymphocytes from peripheral blood and gingiva in health and periodontal disease.
Manakil JF; Sugerman PB; Li H; Seymour GJ; Bartold PM
J Dent Res; 2001 Aug; 80(8):1704-10. PubMed ID: 11669479
[TBL] [Abstract][Full Text] [Related]
35. Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas.
Saqi A; Yun SS; Yu GH; Alexis D; Taub RN; Powell CA; Borczuk AC
Diagn Cytopathol; 2005 Aug; 33(2):65-70. PubMed ID: 16007640
[TBL] [Abstract][Full Text] [Related]
36. Can syndecan-1 become a prognostic factor in solid tumors?
Oguri K; Okayama M
J Gastroenterol; 2004; 39(2):197-9. PubMed ID: 15074308
[No Abstract] [Full Text] [Related]
37. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms.
O'Connell FP; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2004 Feb; 121(2):254-63. PubMed ID: 14983940
[TBL] [Abstract][Full Text] [Related]
38. Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: a multifunctional regulator of cell behavior within the tumor microenvironment.
Dhodapkar MV; Sanderson RD
Leuk Lymphoma; 1999 Jun; 34(1-2):35-43. PubMed ID: 10350330
[TBL] [Abstract][Full Text] [Related]
39. Rearrangement of the bcl-6 gene in Hodgkin's disease, lymphocyte predominant type.
Liang R; Chan WP; Chan AC; Ho FC
Am J Hematol; 1996 May; 52(1):63-4. PubMed ID: 8638618
[No Abstract] [Full Text] [Related]
40. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region.
Flenghi L; Bigerna B; Fizzotti M; Venturi S; Pasqualucci L; Pileri S; Ye BH; Gambacorta M; Pacini R; Baroni CD; Pescarmona E; Anagnostopoulos I; Stein H; Asdrubali G; Martelli MF; Pelicci PG; Dalla-Favera R; Falini B
Am J Pathol; 1996 May; 148(5):1543-55. PubMed ID: 8623923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
